# Workflow 1: Machine Learning Bioactivity Prediction from BGC Sequences

**Paper**: "A machine learning bioinformatics method to predict biological activity from biosynthetic gene clusters"

## Research Objective

- Develop ML method to predict natural product bioactivity from BGC sequences
- Address bioactivity prioritization bottleneck in drug discovery pipeline
- Enable prediction of desired biological functions without production

## Computational Workflow

### STEP 1: BGC Characterization

**INPUT**: 
- BGC sequences from antiSMASH database
- Known bioactivity data for training set (147,000+ BGCs available)
- Genomic context information

**PROCESS**:
- Feature extraction from BGC sequences
- Identification of biosynthetic enzyme types (PKS, NRPS, RiPP, etc.)
- Domain architecture analysis
- Similarity comparison to known BGCs
- Statistical correlation with bioactivities

**OUTPUT**: 
- Feature vectors representing BGC biosynthetic profiles
- Training dataset preparation
- Feature importance assessment
- **Feeds into**: ML model training

---

### STEP 2: Machine Learning Model Development

**INPUT**: 
- Feature vectors and bioactivity labels from Step 1
- Multiple bioactivity categories (antibiotic, antitumor, antifungal, etc.)

**PROCESS**:
- Training on labeled bioactivity dataset
- Feature importance analysis
- Model validation on hold-out test set
- Cross-validation for robustness
- Hyperparameter optimization

**OUTPUT**: 
- Trained ML model for bioactivity prediction
- Model performance metrics
- Feature importance rankings
- **Feeds into**: Large-scale screening

---

### STEP 3: Genome-Wide Bioactivity Prediction

**INPUT**: 
- Trained ML model from Step 2
- 147,000+ identified BGC sequences

**PROCESS**:
- Screen all identified BGCs
- Predict multiple bioactivity types per BGC
- Generate confidence scores
- Prioritize novel scaffolds for experimental validation
- Identify high-priority targets

**OUTPUT**: 
- Ranked prioritization list of BGCs by predicted bioactivity
- Confidence scores for each prediction
- Novel scaffold identification
- **Feeds into**: Experimental prioritization and BGC activation

---

### STEP 4: Experimental Validation Design

**INPUT**: 
- Priority BGCs from Step 3
- Target bioactivity functions

**PROCESS**:
- Selection of BGCs for experimental testing
- BGC activation strategy planning
- Production optimization specifications
- Bioactivity assay design

**OUTPUT**: 
- Experimentally validated bioactive compounds from priority BGCs
- Improved drug discovery pipeline efficiency
- Validated ML predictions for future iterations

---

## Final Experimental Product

**Prioritized bioactive compounds** with:
- Predicted bioactivities from BGC sequences
- Experimentally confirmed bioactivity
- Novel drug scaffolds identified
- Streamlined discovery pipeline

## Key Computational Tools

- BGC identification: antiSMASH, ClusterMine, MINER
- Feature extraction: Custom Python scripts
- Machine learning: scikit-learn, XGBoost, TensorFlow
- Sequence analysis: Biopython, seqkit
- Database management: SQL, MongoDB
- Data visualization: Matplotlib, Plotly, Pandas
